Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K4 | P45985 | 6/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.53 |
| ▸ | BRAF | P15056 | 5/20 | 0.51 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.51 |
| ▸ | RAF1 | P04049 | 2/20 | 0.51 |
| ▸ | KDR | P35968 | 2/20 | 0.51 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.51 |
| ▸ | TGFBR2 | P37173 | 2/20 | 0.51 |
| ▸ | NEK2 | P51955 | 2/20 | 0.51 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.51 |
| ▸ | TNK2 | Q07912 | 2/20 | 0.51 |
| ▸ | MAP2K5 | Q13163 | 2/20 | 0.51 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.51 |
| ▸ | NEK11 | Q8NG66 | 2/20 | 0.51 |
| ▸ | MAP3K20 | Q9NYL2 | 2/20 | 0.51 |
| ▸ | MAP4K5 | Q9Y4K4 | 2/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | KRAS | P01116 | 1/20 | 0.51 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26107467 | 1.00 | MAP2K4 (0.59) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL26111528 | 0.96 | MAP2K4 (0.58) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL29898604 | 0.96 | MAP2K4 (0.58) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL20408845 | 0.88 | MAP2K4 (0.75) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL29725808 | 0.88 | MAP2K4 (0.75) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL21624550 | 0.88 | CYP2C9 (0.69) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL30866635 | 0.88 | CYP2C9 (0.69) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL29898643 | 0.87 | MAP2K4 (0.60) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL26108806 | 0.87 | MAP2K4 (0.60) | MAP2K4CYP2C9BRAFRIPK2RAF1 | |
| SCHEMBL29898622 | 0.86 | BRAF (0.58) | MAP2K4CYP2C9BRAFRIPK2RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228834-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER | HEPAREGENIX GMBH (DE) | 2025-07-17 | — | — | US | disclosed |
| EP-4504185-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER | HepaRegeniX GmbH (DE) | 2025-02-12 | — | — | EP | disclosed |
| US-11912701-B2 | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death | HEPAREGENIX GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| WO-2023194443-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER | HEPAREGENIX GMBH (DE) | 2023-10-12 | — | — | WO | disclosed |
| US-20220281864-A1 | PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | HEPAREGENIX GMBH (DE) | 2022-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912701-B2 | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death | MAPK4, MAPK7, MAPK14 | MAP2K4 22/4885CYP2C9 1742/4885BRAF 64/4885 |
| US-20250228834-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER | KRAS, MAPK4, NRAS | MAP2K4 70/4885CYP2C9 3193/4885BRAF 27/4885 |
| US-20220281864-A1 | PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | MAPK4, MAPK7, MAPK14 | MAP2K4 22/4885CYP2C9 1814/4885BRAF 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.